Skip to main content
Fig. 2 | BMC Medicine

Fig. 2

From: Low awareness of the transitivity assumption in complex networks of interventions: a systematic survey from 721 network meta-analyses

Fig. 2

Bar plots on the methods described in the systematic review report for transitivity evaluation among systematic reviews published before and after the PRISMA-NMA statement: 279 systematic reviews before and 292 after PRISMA-NMA reported at least one method for transitivity or statistical heterogeneity assessment. A systematic review may have reported more than one method. Dark blue refers to direct and indirect methods used exclusively for transitivity assessment. Light blue refers to indirect methods used exclusively to investigate sources of statistical heterogeneity. A Justifying treatment similarity in different trials. B Justifying treatments as missing at random. C Justifying participants as jointly randomisable. D Comparison comparability regarding important effect modifiers. E Sensitivity analysis. F Subgroup analysis. G Meta-regression. H Consistency evaluation

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us